Axim Biotechnologies Inc AXIM:OTCQB

Last Price$0.54NASDAQ Last Trade (15-minute delayed) as of 3:17PM ET 6/02/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+0.03(6.24%)
Bid (Size)$0.53 (1,200)
Ask (Size)$0.54 (1,000)
Day Low / High$0.52 - 0.56
Volume404.3 K
 

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionAXIM Biotechnologies, Inc. is a biotechnology company. It focuses in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. The firm also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in New York, NY. View company web site for more details
Address45 Rockefeller Plaza
New York, New York 10111
Phone+1.212.332.1677
Number of Employees6
Recent SEC Filing05/29/20208-K/A
Chief Executive Officer & DirectorJohn W. Huemoeller
Chief Financial Officer & SecretaryRobert T. Malasek

Company Highlights

Price Open$0.52
Previous Close$0.51
52 Week Range$0.10 - 1.08
Market Capitalization$68.9 M
Shares Outstanding128.4 M
SectorIndustrial Services
IndustryEnvironmental Services
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.11
Beta vs. S&P 500N/A
Revenue$195.6 K
Net Profit Margin-806.47%
Return on Equity105.76%